3. OUTCOME AND FOLLOW-UP
After emergency surgery, the patient recovered uneventfully. He was referred to the medical oncology team for further appropriate postoperative management. Subsequently, he received standard chemotherapeutic regimens (called Rituximab-CHOP) scheduled was administrated. Unfortunately, the patient sustained acute critical conditions presented hemodynamic worsen gradually, congestive heart failure, complicated hospital bacterial infection, massive pleural effusion with acute respiratory failure and hypovolemic shock related acute kidney failure developed. The patient expired six months after surgery.